Events
28.10.2021

Connect with Cromos Pharma at 40th JP Morgan Healthcare Conference

Meet with Cromos Pharma during the 40th JP Morgan Healthcare Conference, January 2022. Cromos Pharma is delighted to be participating again at this prestigious invite-only event.

LET OUR EXPERIENCE BENEFIT YOUR NEXT CLINICAL PROGRAM

Our mission is to support our partners in advancement of their clinical development programs that to improve the lives of the patients around the world. 

We look forward to sharing with you the advantages of partnering with Cromos Pharma including:

  • International expertise combined with in-depth regional knowledge in Central and Eastern Europe (300+ clinical trials conducted in 70+ indications). 
  • Extensive PI/site and patient network (40,000+ patients enrolled from nearly 2,500 trial sites).
  • Unparalleled patient recruitment – our team met or shortened project timelines in 95% of conducted trials.
  • Extremely short startup timelines (e.g. Georgia where we assure a study launch in less than 2 months).
  • Expertise in innovative, generics and biosimilar global studies (NDAs, ANDAs, BLAs, 505b2).
  • Regulatory inspections and audits that attest to the highest quality of data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
  • Clinical Development Strategy – we provide expert guidance on study design, favorable venues, local and global landscape to improve study outcomes.

You can also find out more about availing of Cromos Pharma’s special programs including:

FREE FEASIBILITY REPORTS 

Free Feasibility Reports for sponsors considering expanding their clinical trials into Central and Eastern Europe. You confidentially provide us with your protocol, synopsis, or trial outline and in just two weeks our expert team will deliver a detailed feasibility report including: 

  • Competitive landscape 
  • Review of local standards of care 
  • Historical recruitment statistics 
  • Regulatory requirements and timelines 
  • Realistic recruitment projections

NO PATIENTS – NO PAYMENT

“No Patients - No Payment” is Cromos Pharma’s proprietary risk sharing program through which we give our assurance that your enrollment goals, budgets, and timelines will be met.  Simply put, if we don’t recruit – you don’t pay. 

ABOUT CROMOS PHARMA 

Cromos Pharma is a US-based international contract research organization with 16 years of experience in delivering fully integrated clinical research solutions in all aspects of clinical trials in all clinical phases across a wide range of therapeutic areas. Our expert team boasts wide-ranging expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management. From biosimilars and generics to successfully managing oncology, neurology, dermatology clinical trials our team provides full service solutions to international pharma and biotech in high recruiting regions with high quality data assured. Established in 2004, Cromos Pharma has strong regional experience in Central and Eastern Europe supported by an extensive network of offices. Its international HQ is in Portland, Oregon, USA and EU HQ in Dublin, Ireland.

CONTACT US TODAY TO ARRANGE A MEETING BD@CROMOSPHARMA.COM



Other Events:
news

Meet us during BIO-Europe Spring 22 -25 March

Cromos Pharma is delighted to be participating in BIO-Europe Spring (22 - 25 March, 2021). Set up a meeting with us today!
09.03.2021
news

Meet with us at DIA Europe 15 - 19 March

Cromos Pharma is looking forward to taking part in the upcoming DIA Europe conference (15 – 19 March 2021).  A highly collaborative event, it’s a great chance to meet with future partners and hear from innovators across the entire life sciences spectrum. 

02.03.2021
news

Cromos Pharma at OCT West Coast 2021

Outsourcing in Clinical Trials West Coast 2021 is just around the corner (24 – 25 February) and we are looking forward to participating in this year’s virtual event. 
17.02.2021
news

Visit our Virtual Booth at the JP Morgan Healthcare Conference 2021

This year the JP Morgan Healthcare Conference is going virtual and so are we! We have been meeting you at this event for the past 11 years and there is no way we are going to break with that tradition this year.  So we are delighted to be hosting a VIRTUAL CROMOS PHARMA BOOTH January 11th through 14th from 8 am to 5 pm (PST).
30.12.2020
news

Happy Hanukkah from Cromos Pharma

Wishing you all a wonderful season filled with light, hope and health! From all of us at Cromos Pharma #hanukkah #happyholidays
10.12.2020
news

Cromos Pharma at The San Antonio Breast Cancer Symposium 2020

We are delighted to taking part again in this year's San Antonio Breast Cancer Symposium (8-11 December). We invite you to arrange a meeting with our team to discuss how we can support your trials in this area. 


30.11.2020
news

Meet Cromos Pharma at the 62nd ASH Annual Meeting & Exposition

Cromos Pharma is delighted to be participating again this year at the 62nd ASH Annual Meeting & Exposition 5-8 December, 2020, the premier event for malignant and non-malignant hematology. We would like to invite you to set up an online meeting with us. 
24.11.2020
news

Join Cromos Pharma at World Orphan Drug Congress-Europe 2020

We are just one week away from the virtual World Orphan Drug Congress Europe 2020. Cromos Pharma is delighted to be participating in this event and invite you to join us from 2-5 November. Register here and connect with us via the partnering platform or email bd@cromospharma.com to set up a meeting.
27.10.2020
news

Cromos Pharma at GRx+Biosims November 9-11, 2020

Cromos Pharma is delighted to be participating in the upcoming GRx+Biosims 2020 (9-11 November). We look forward to this virtual event which is consistently one of the highlights of the year for biosimilar and generic sectors.
26.10.2020
news

Cromos Pharma at BIO-Europe Digital Oct 26-29

Cromos Pharma is delighted to be participating in BIO-EUROPE Digital, 26 -29 October. It promises to be an exciting event with themes including innovation and digital health in the context of the ongoing pandemic and stimulating sessions focusing on collaboration and partnering. We look forward to connecting with you at the event. 
06.10.2020
news

Connect with Cromos Pharma at MAGI's Clinical Research vConference

Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).

17.09.2020